Trademark Details For ALVAIZ (Serial Number 97636800)

  •  Home
  •  Print
ALVAIZ
1
3
2
0
word.basic_information
Serial Number  United States - USPTO 97636800
Registration Number 7409877
Mark
ALVAIZ
Filing Date Oct-18-2022
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0


  • TEVA PHARMACEUTICALS USA


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Nov-01-2023

First Use in Commerce: Dec-01-2023





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 UNITED STATES

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-21-2022NEW APPLICATION ENTERED   NWAPI
Nov-02-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Mar-28-2023ASSIGNED TO EXAMINER   DOCKD
Mar-28-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Apr-12-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
May-02-2023PUBLISHED FOR OPPOSITION   PUBOA
May-02-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jun-27-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Dec-21-2023SOU TEAS EXTENSION RECEIVED   EEXTI
Dec-21-2023SOU EXTENSION 1 FILED   EXT1S
Dec-21-2023SOU EXTENSION 1 GRANTED   EX1GS
Dec-23-2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Mar-21-2024TEAS STATEMENT OF USE RECEIVED   EISUI
Apr-11-2024CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Mar-21-2024USE AMENDMENT FILED   IUAFS
Apr-11-2024STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Apr-25-2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Apr-25-2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Jun-04-2024REGISTERED-PRINCIPAL REGISTER   R.PRA
Jun-04-2024NOTICE OF REGISTRATION CONFIRMATION EMAILED   NRCCE

LOADING